QUANTRX BIOMEDICAL CORP - FORM 10-Q - EX-32 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - November 20, 2017

Attached files

file filename
EX-31 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - QUANTRX BIOMEDICAL CORPex31.htm
EX-10.1 - FORM OF CONVERTIBLE PROMISSORY DEMAND NOTE. - QUANTRX BIOMEDICAL CORPex10-1.htm
10-Q - QUARTERLY REPORT - QUANTRX BIOMEDICAL CORPqtxb10q_sep302017.htm
 
Exhibit 32
 
CERTIFICATION PURSUANT TO 18 U.S.C. §1350
 
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 In connection with the accompanying Quarterly Report of QuantRx Biomedical Corporation (the "Company") on Form 10-Q for the period ending September 30, 2017, as filed with the Securities and Exchange Commission on or about the date hereof (the "Report"), the undersigned, Shalom Hirschman, Principal Executive and Principal Financial and Accounting Officer of the Company, certifies, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
 
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 
 
 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
    
 
   
 
Date:  November 20, 2017
/s/ Shalom Hirschman
 
Shalom Hirschman
Principal Executive, Financial and Accounting Officer
 
 
 
 

QUANTRX BIOMEDICAL CORP Reports